Investment Stage

Focus Areas

About Investor

David Malek is a Venture Partner at Pivotal bioVenture Partners based in San Francisco, California, specializing in investments in BioTech and Therapeutics sectors across Seed, Series A, and Series B stages with investment ranges of $100K - $5.0M. His professional background includes serving as Chief Business Officer at BioLineRx (NASDAQ: BLRX), a drug development company, bringing valuable pharmaceutical industry experience to his investment role. Malek joined Pivotal Life Sciences in 2018 and also serves as Director at Avalyn Pharma, demonstrating his continued leadership in the biotechnology sector. His deep expertise in drug development and life sciences enables him to identify promising biotech companies with strong clinical and commercial potential.